15 Jul 2026
Wilson Sonsini Goodrich & Rosati Expands Healthcare Regulatory Practice with Brandon Ge and Ty Kayam
"Wilson Sonsini Goodrich & Rosati has hired Brandon Ge (health data privacy, cybersecurity, AI governance) and Ty Kayam (digital health, FDA and AI regulatory strategy) to its Healthcare Regulatory practice."
Brandon Ge — Senior Counsel, Washington, D.C.
Ge advises healthcare and technology companies on data privacy, cybersecurity, and AI governance, including incident response, interoperability and information blocking, data use and exchange, and privacy-related contracting. His experience includes counseling clients on the Health Insurance Portability and Accountability Act (HIPAA), 42 C.F.R. Part 2, the Health Breach Notification Rule, the Federal Trade Commission Act, and state and international privacy laws, and representing clients in regulatory investigations before the U.S. Department of Health and Human Services Office for Civil Rights and state attorneys general. Ge has led privacy and security due diligence for healthcare and technology transactions, including acquisitions by one of the nation’s largest health insurers and a multibillion-dollar acquisition by one of the world’s largest technology companies. He holds CIPP/US, CIPM, and AIGP certifications and received his J.D. from Columbia Law School and his B.A. from the University of Maryland, College Park.
Ty Kayam — Of Counsel, Seattle
Kayam advises companies and investors on regulatory strategy for health technology products, with a particular focus on health AI, digital health, wearables, medical robotics, and health data infrastructure. She counsels clients throughout product development and commercialization and on health regulatory issues arising in financings, investments, partnerships, and strategic transactions. Kayam joins Wilson Sonsini after serving as the first attorney in the U.S. Food and Drug Administration’s Digital Health Center of Excellence, where she helped shape the agency’s approach to software and AI-enabled medical technologies, including evidentiary expectations, predetermined change control plans, and pre- and post-market considerations. Previously, she was senior corporate counsel at Microsoft, advising product, engineering, and business teams developing health technologies — including products incorporating generative AI and foundation models — and helping to develop Microsoft’s global regulatory and policy strategy for its health business. She holds a J.D. from Northeastern University School of Law, a Master of Public Health from Tufts University, and a B.S. from Acadia University.